Requires the commissioner of health to establish and publish a list of generic drug products; repealer

S 5580 requires New York's health commissioner to create and publish a list of generic drugs meeting FDA safety and efficacy standards, including those with therapeutic equivalence. The bill mandates that manufacturers provide the state with bioequivalence data and other supporting information, which must be made freely available online. This list will determine which generic drugs can be substituted by pharmacists without a prescriber's "Dispense As Written" (DAW) notation on prescriptions. The law also repeals an outdated section of public health law and updates prescription form requirements to ensure pharmacists can substitute approved generics unless explicitly prohibited by the prescriber.